Vic Myer compensation by year
Editas Medicine Summary Compensation Table · all 2 fiscal years held| Component | FY2018 | FY2019 |
|---|---|---|
| Salary | $363,377 | $287,906 |
| Bonus | $0 | $0 |
| Stock awards | $0 | $534,807 |
| Option awards | $1,946,460 | $701,454 |
| Non-equity incentive | $123,549 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $22,353 | $84,550 |
| Total | $2,455,739 | $1,608,717 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Editas Medicine, Inc. DEF 14A filed April 28, 2020, accession 0001047469-20-002641, and prior-year filings.
How this page was built: the Editas Medicine, Inc. filed document, accession 0001047469-20-002641. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2020.
Editas Medicine’s named executive officers, FY2019
as the company reported each| Named executive officer | Role | FY2019 total |
|---|---|---|
| Cynthia Collins | Former President and Chief Executive Officer | $14,489,736 |
| Judith Abrams | Former Chief Medical Officer | $2,825,252 |
| Charles Albright | Former Executive Vice President and Chief Scientific Officer | $1,996,323 |
| Vic Myer · this page | Former Chief Technology Officer | $1,608,717 |
| Eric Ek | Former interim Chief Financial Officer | $1,139,984 |
| Katrine Bosley | Former President and Chief Executive Officer | $661,240 |
| Andrew Hack | Former Chief Financial Officer | $70,187 |
The full Editas Medicine compensation record
free company briefThis page is one person within Editas Medicine's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Editas Medicine proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Editas Medicine's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.